-
1
-
-
65249182083
-
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): Rationale and study design
-
H.H. Parving, B.M. Brenner, J.J. McMurray Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol Dial Transplant 24 2009 1663 1671
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 1663-1671
-
-
Parving, H.H.1
Brenner, B.M.2
McMurray, J.J.3
-
2
-
-
44849114597
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy
-
H.H. Parving, F. Persson, J.B. Lewis Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2008 2433 2446
-
(2008)
N Engl J Med
, vol.358
, pp. 2433-2446
-
-
Parving, H.H.1
Persson, F.2
Lewis, J.B.3
-
3
-
-
79955463305
-
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
-
S.D. Solomon, S.H. Shin, A. Shah Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction Eur Heart J 32 2011 1227 1234
-
(2011)
Eur Heart J
, vol.32
, pp. 1227-1234
-
-
Solomon, S.D.1
Shin, S.H.2
Shah, A.3
-
4
-
-
0342894669
-
Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
-
J. Menard, D.J. Campbell, M. Azizi, M.F. Gonzales Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats Circulation 96 1997 3072 3078
-
(1997)
Circulation
, vol.96
, pp. 3072-3078
-
-
Menard, J.1
Campbell, D.J.2
Azizi, M.3
Gonzales, M.F.4
-
5
-
-
38049139424
-
Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease
-
R. Kunz, C. Friedrich, M. Wolbers, J.F. Mann Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48
-
(2008)
Ann Intern Med
, vol.148
, pp. 30-48
-
-
Kunz, R.1
Friedrich, C.2
Wolbers, M.3
Mann, J.F.4
-
6
-
-
0037431774
-
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial
-
N. Nakao, A. Yoshimura, H. Morita Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial Lancet 361 2003 117 124
-
(2003)
Lancet
, vol.361
, pp. 117-124
-
-
Nakao, N.1
Yoshimura, A.2
Morita, H.3
-
7
-
-
77956897268
-
Introducing the most wanted Lancet articles
-
P. Pini Introducing the most wanted Lancet articles Lancet 361 2003 1265
-
(2003)
Lancet
, vol.361
, pp. 1265
-
-
Pini, P.1
-
8
-
-
84873705219
-
-
Accessed December 25, 2011
-
SDI, Plymouth Meeting PA www.SDIhealth.com Accessed December 25, 2011
-
SDI, Plymouth Meeting PA
-
-
-
9
-
-
49149087718
-
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
-
J.F. Mann, R.E. Schmieder, M. McQueen Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Lancet 372 2008 547 553
-
(2008)
Lancet
, vol.372
, pp. 547-553
-
-
Mann, J.F.1
Schmieder, R.E.2
McQueen, M.3
-
10
-
-
43049149377
-
The COOPERATE trial: A letter of concern
-
R. Kunz, M. Wolbers, T. Glass, J.F. Mann The COOPERATE trial: a letter of concern Lancet 371 2008 1575 1576
-
(2008)
Lancet
, vol.371
, pp. 1575-1576
-
-
Kunz, R.1
Wolbers, M.2
Glass, T.3
Mann, J.F.4
-
11
-
-
70349771914
-
Retraction-Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial
-
Retraction-Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial Lancet 374 2009 1226
-
(2009)
Lancet
, vol.374
, pp. 1226
-
-
-
12
-
-
79959504988
-
Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: Observations from traditional and Bayesian random-effects meta-analyses of randomized trials
-
9 p following 810
-
S. Bangalore, S. Kumar, I. Lobach, F.H. Messerli Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials Circulation 123 2011 2799 2810 9 p following 810
-
(2011)
Circulation
, vol.123
, pp. 2799-2810
-
-
Bangalore, S.1
Kumar, S.2
Lobach, I.3
Messerli, F.H.4
-
13
-
-
79952373965
-
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
-
H. Haller, S. Ito, J.L. Izzo Jr Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes N Engl J Med 364 2011 907 917
-
(2011)
N Engl J Med
, vol.364
, pp. 907-917
-
-
Haller, H.1
Ito, S.2
Izzo, Jr.J.L.3
-
14
-
-
0001285263
-
Clinical practice recommendations
-
American Diabetes Association
-
American Diabetes Association Clinical practice recommendations Diabetes Care 36 2013 S1 S110
-
(2013)
Diabetes Care
, vol.36
-
-
|